Published in Blood Weekly, September 5th, 2002
Micrologix will receive up to US$21 million in up-front and milestone payments, as well as a royalty of 20% on sales of the product.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.